View in EDS HTML Full Text PDF Full Text

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.

Saved in:
Bibliographic Details
Title: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
Authors: Katlama C; Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Pitié-Salpêtrière, Service des Maladies Infectieuses et Tropicales, Paris, France.; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France., Assoumou L; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France., Valantin MA; Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Pitié-Salpêtrière, Service des Maladies Infectieuses et Tropicales, Paris, France.; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France., Soulié C; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.; APHP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France., Martinez E; Infectious Diseases Unit, Hospital Clinic and University of Barcelona, Barcelona, Spain., Béniguel L; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France., Bouchaud O; Assistance Publique-Hôpitaux de Paris (APHP), Centre Hospitalier Universitaire Avicenne, Service des Maladies Infectieuses et Tropicales, Bobigny, France.; Université Paris 13, IMEA-Fondation Internationale Léon Mba, Paris, France., Raffi F; INSERM CIC 1413, Université de Nantes, Département des Maladies Infectieuses, Hôpital Hôtel-Dieu, Nantes, France., Molina JM; Université Paris Diderot, Paris, France, Sorbonne Paris Cité, APHP, Hôpital Saint-Louis, Paris, France., Fellahi S; Sorbonne Université, INSERM UMRS_938, Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Paris, France., Peytavin G; INSERM UMR 1137, Université Paris 7, Laboratoire de Pharmacologie-Toxicologie, Hôpital Bichat-Claude Bernard, APHP, Paris, France., Marcelin AG; APHP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France., Kolta S; Département de rhumatologie, Hôpital Cochin, Paris, France - INSERM UMR-1153, Paris, France., Capeau J; Sorbonne Université, INSERM UMRS_938, Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Paris, France., Gibowski S; ANRS, France Recherche Nord & Sud Sida-Hiv Hépatites, Agence autonome de l'INSERM, Paris, France., Cardon F; ANRS, France Recherche Nord & Sud Sida-Hiv Hépatites, Agence autonome de l'INSERM, Paris, France., Reynes J; Département de maladies infectieuses, UMI 233 INSERM U1175, CHU de Montpellier, Montpellier, France., Costagliola D; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2020 Dec 01; Vol. 75 (12), pp. 3699-3700.
Publication Type: Letter; Comment
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32954404
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Katlama+C%22">Katlama C</searchLink>; Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Pitié-Salpêtrière, Service des Maladies Infectieuses et Tropicales, Paris, France.; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Assoumou+L%22">Assoumou L</searchLink>; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Valantin+MA%22">Valantin MA</searchLink>; Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Pitié-Salpêtrière, Service des Maladies Infectieuses et Tropicales, Paris, France.; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Soulié+C%22">Soulié C</searchLink>; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.; APHP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Martinez+E%22">Martinez E</searchLink>; Infectious Diseases Unit, Hospital Clinic and University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Béniguel+L%22">Béniguel L</searchLink>; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Bouchaud+O%22">Bouchaud O</searchLink>; Assistance Publique-Hôpitaux de Paris (APHP), Centre Hospitalier Universitaire Avicenne, Service des Maladies Infectieuses et Tropicales, Bobigny, France.; Université Paris 13, IMEA-Fondation Internationale Léon Mba, Paris, France.<br /><searchLink fieldCode="AU" term="%22Raffi+F%22">Raffi F</searchLink>; INSERM CIC 1413, Université de Nantes, Département des Maladies Infectieuses, Hôpital Hôtel-Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Molina+JM%22">Molina JM</searchLink>; Université Paris Diderot, Paris, France, Sorbonne Paris Cité, APHP, Hôpital Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Fellahi+S%22">Fellahi S</searchLink>; Sorbonne Université, INSERM UMRS_938, Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Paris, France.<br /><searchLink fieldCode="AU" term="%22Peytavin+G%22">Peytavin G</searchLink>; INSERM UMR 1137, Université Paris 7, Laboratoire de Pharmacologie-Toxicologie, Hôpital Bichat-Claude Bernard, APHP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Marcelin+AG%22">Marcelin AG</searchLink>; APHP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kolta+S%22">Kolta S</searchLink>; Département de rhumatologie, Hôpital Cochin, Paris, France - INSERM UMR-1153, Paris, France.<br /><searchLink fieldCode="AU" term="%22Capeau+J%22">Capeau J</searchLink>; Sorbonne Université, INSERM UMRS_938, Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Paris, France.<br /><searchLink fieldCode="AU" term="%22Gibowski+S%22">Gibowski S</searchLink>; ANRS, France Recherche Nord & Sud Sida-Hiv Hépatites, Agence autonome de l'INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cardon+F%22">Cardon F</searchLink>; ANRS, France Recherche Nord & Sud Sida-Hiv Hépatites, Agence autonome de l'INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Reynes+J%22">Reynes J</searchLink>; Département de maladies infectieuses, UMI 233 INSERM U1175, CHU de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Costagliola+D%22">Costagliola D</searchLink>; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227513617%22">The Journal of antimicrobial chemotherapy</searchLink> [J Antimicrob Chemother] 2020 Dec 01; Vol. 75 (12), pp. 3699-3700.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7513617 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057453%22">03057453 </searchLink><i>NLM ISO Abbreviation: </i>J Antimicrob Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32954404
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jac/dkaa341
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3699
    Titles:
      – TitleFull: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Katlama C
      – PersonEntity:
          Name:
            NameFull: Assoumou L
      – PersonEntity:
          Name:
            NameFull: Valantin MA
      – PersonEntity:
          Name:
            NameFull: Soulié C
      – PersonEntity:
          Name:
            NameFull: Martinez E
      – PersonEntity:
          Name:
            NameFull: Béniguel L
      – PersonEntity:
          Name:
            NameFull: Bouchaud O
      – PersonEntity:
          Name:
            NameFull: Raffi F
      – PersonEntity:
          Name:
            NameFull: Molina JM
      – PersonEntity:
          Name:
            NameFull: Fellahi S
      – PersonEntity:
          Name:
            NameFull: Peytavin G
      – PersonEntity:
          Name:
            NameFull: Marcelin AG
      – PersonEntity:
          Name:
            NameFull: Kolta S
      – PersonEntity:
          Name:
            NameFull: Capeau J
      – PersonEntity:
          Name:
            NameFull: Gibowski S
      – PersonEntity:
          Name:
            NameFull: Cardon F
      – PersonEntity:
          Name:
            NameFull: Reynes J
      – PersonEntity:
          Name:
            NameFull: Costagliola D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2020 Dec 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2091
          Numbering:
            – Type: volume
              Value: 75
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: The Journal of antimicrobial chemotherapy
              Type: main
ResultId 1